About this trial
Investigators hypothesize that CPAP treatment for suppressing OSAS in combination with a physical activity program will optimize 24-hour blood pressure control in patients with OSA-related resistant hypertension.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patient with an obstructive sleep apnea (apnea-hypopnea index > or equal to 15)
Patient with resistant hypertension uncontrolled by 3 or more antihypertensive agents
Ambulatory patient
Disqualifiers
Acute hepatic failure, biliary cirrhosis, cholestasis
Acute hypertension (SBP>= 180 mmHg and/or DBP >= 110 mmHg)
Contraindication to CPAP treatment
Trial design
Parallel
Treatments tested in this trial
Physical activity
Other interventionPhysical activity will carry out 3 times per week during 12 weeks for intervention arm
Treatment groups
Trial outcomes
Primary outcomes
Systolic arterial blood pressure assessed by 24-hours home blood pressure monitoring
Systolic arterial blood pressure assessed by 24-hours home blood pressure monitoring
Secondary outcomes
diastolic arterial blood pressure assessed by 24-hours home blood pressure monitoring
diastolic arterial blood pressure assessed by 24-hours home blood pressure monitoring
Mean arterial blood pressure assessed by 24-hours home blood pressure monitoring
Mean arterial blood pressure assessed by 24-hours home blood pressure monitoring
Change in physical activity: number of hour per day of physical activity
Change in physical activity: number of hour per day of physical activity
pulse wave velocity
pulse wave velocity
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
AGIR à Dom
Lead sponsor
University Hospital, Grenoble
Collaborator